Background-Intravascular optical coherence tomography (IVOCT) images are recorded by detecting light backscattered within coronary arteries. We hypothesize that non-thin-capped fibroatheroma (TCFA) causes may scatter light to create the false appearance of IVOCT TCFA. Methods and Results-Ten human cadaver hearts were imaged with IVOCT (n=14 coronary arteries). IVOCT and histological TCFA images were coregistered and compared. Of 21 IVOCT TCFAs (fibrous cap <65 μm, lipid arc >1 quadrant), only 8 were true histological TCFA. Foam cell infiltration was responsible for 70% of false IVOCT TCFA and caused both thick-capped fibroatheromas to appear as TCFA, and the appearance of TCFAs when no lipid core was present. Other false IVOCT TCFA causes included smooth muscle cell-rich fibrous tissue (12%) and loose connective tissue (9%). If the lipid arc >1 quadrant (obtuse) criterion was disregarded, 45 IVOCT TCFAs were identified, and sensitivity of IVOCT TCFA detection increased from 63% to 87%, and specificity remained high at 92%. Conclusions-We demonstrate that IVOCT can exhibit 87% (95% CI, 75%-93%) sensitivity and 92% specificity (95% CI, 86%-96%) to detect all lipid arcs (both obtuse and acute, <1 quadrant) TCFA, and we also propose new mechanisms involving light scattering that explain why other plaque components can masquerade as TCFA and cause low positive predictive value of IVOCT for TCFA detection (47% for obtuse lipid arcs). Disregarding the lipid arc >1 quadrant requirement enhances the ability of IVOCT to detect TCFA. (Circ Cardiovasc Interv. 2016;9:e003163.
P laque rupture is responsible for up to 75% of acute coronary syndromes and is an important mechanism for atherosclerotic disease progression. Plaque rupture is most often preceded by the development of a thin-capped fibroatheroma (TCFA), the most common type of vulnerable plaque. 1, 2 Intravascular optical coherence tomography (IVOCT) is the only coronary imaging modality available clinically that has sufficient resolution to identify the thin fibrous cap of a TCFA (<65 µm) overlaying a large lipid core. 3 Although some studies have shown that IVOCT is accurate for imaging TCFA, [4] [5] [6] other studies have reported the false identification of TCFA with IVOCT. Two studies with histological validation have been reported that describe superficial foam cell infiltration that causes strong light attenuation and appears as a lipid pool or TCFA. 7, 8 Another known mechanism for the false
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appearance of TCFA is tangential light dropout, which occurs when light emitted from the IVOCT catheter propagates tangential to the luminal wall. 3 Similarly, Manfrini et al 9 demonstrated in ex vivo human hearts that only 45% of fibrous cap atheromas were correctly identified by IVOCT because of either low IVOCT signal penetration depth or the inability to distinguish calcium deposits from lipid. Finally, Fujii et al 10 recently reported only 41% positive predictive value (PPV) of IVOCT for TCFA identification. These studies suggest the need for a more comprehensive histological validation of IVOCT identification of TCFAs.
The wavelength of light used for IVOCT imaging of coronary arteries (1310±50 nm) results in images that are created Light Scattering Effects on IVOCT TCFA predominantly based on a light-scattering mechanism. 3 Hence, bright regions in IVOCT images are caused by light that is strongly backscattered to the imaging catheter (eg, fibrous cap), whereas dark regions (eg, lipid) correspond to decreased backscattered light returning to the catheter. Light absorption is a minor contributor to IVOCT image contrast in coronary arteries. A decreased light amplitude returning to the catheter can be because of at least 2 types of mechanisms ( Figure 1 
Methods

Specimens
Ten human hearts (3 women and 7 men) were acquired through the Southwest Blood & Tissue Center and examined within 24 hours of death. The average age at death was 65±11 years. Six deaths were cardiac related including 4 acute myocardial infarctions. One death was caused by a cerebrovascular event. Evidence of plaque rupture and thrombus was found by both IVOCT and histology in 5 patients. We imaged 14 coronary arteries (n=10 left anterior descending artery [LAD] and n=4 right coronary artery). The Institutional Review Board at the University of Texas approved this study.
Imaging Procedure
A human heart catheterization laboratory was recreated with a custom IVOCT system (Volcano Corporation, San Diego, CA) as reported previously. 11 Briefly, a 1310-nm swept source laser was used to image the LAD and right coronary artery (80-mm pullbacks recorded by 300 IVOCT images). Left and right coronary 6F guide catheters were sewn into the coronary ostia, 0.014″ guidewire access to the coronary arteries was gained under fluoroscopic guidance, and a metallic stent was deployed 80 mm from the guide catheter tip as a fiduciary marker. The tissue was maintained at 37°C with a customdesigned imaging chamber. After imaging, the right coronary artery and LAD were perfusion fixed with 10% neutral-buffered formalin at 100 mm Hg. The left circumflex artery was not imaged because of its tortuosity in the ex vivo heart.
WHAT IS KNOWN
• Intravascular optical coherence tomography (IVOCT) is the only clinical technique capable of imaging the thin fibrous cap of the thin-capped fibroatheroma (TCFA), but image artifacts can cause IVOCT images to falsely appear as TCFAs, such as superficial macrophage infiltration and tangential light dropout.
WHAT THE STUDY ADDS
• This study characterizes intramural components that cause IVOCT images to falsely display TCFAs, the absence of which is proven by rigorous histological analysis and proposes new light-scattering mechanisms for the appearance of these false-positives.
• We demonstrate that IVOCT can exhibit 85% sensitivity and 93% specificity for identification of TCFA and also explain the low positive predictive value for IVOCT TCFA detection in our own study, consistent with others in the literature.
• In a cohort of n=14 human coronary arteries, we quantify the frequency of several false TCFA causes that include superficial macrophages, tangential light dropout, loose connective tissue, punctate foam cells, and smooth muscle cell infiltration of the fibrous cap.
• Sensitivity for IVOCT TCFA detection can be increased if lipid arc lengths <1 quadrant are also considered TCFA; however, because this decreases further the positive predictive value and specificity of IVOCT TCFA detection, we suggest that IVOCT TCFA definitions should be further studied and clarified, perhaps even with the addition of new imaging modalities more specific to the presence of lipid in the arteries, such as fluorescence lifetime imaging or 2-photon luminescence. 
Histology
The LADs and right coronary arteries were dissected and processed routinely for histology as in a previous study. 11 Tissue was decalcified overnight with Cal-Rite (Richard Allen Scientific) if necessary. The arteries were sliced into 2-to 3-mm-thick rings and further processed for standard paraffin-embedded sections. An average of 25 rings was generated from each artery. Serial tissue sections (5-μm thick) were cut at 120-μm intervals and stained with hematoxylin and eosin, modified Movat pentachrome, and Von Kossa. Anti-CD68 (Dako North America, Inc, Carpinteria, CA) and anti-α-SMC and smooth muscle actin (Sigma-Aldrich, St. Louis, MO) antibodies were used in immunohistochemical studies to identify macrophages and SMCs, respectively.
IVOCT and Histology Coregistration
Each histological ring was matched to a respective IVOCT image as detailed previously. 11 Coregistration was performed between IVOCT images and histological sections on the basis of (1) 2 fiducial landmarks (the sewn-in guide catheter and a distally deployed stent, marking the at the proximal and distal ends of the pullback, respectively) that were visible in IVOCT images, fluoroscopy, and radiography before histopathologic processing; (2) a mathematical calculation based on the physical position of IVOCT images in the pullbacks measured against the estimated distance in microns from the fiducial landmarks in the tissue sections; and (3) anatomic landmarks (eg, arterial branches or calcification patterns) and luminal geometric features when present. Two researchers independently coregistered recorded IVOCT images and histological sections, and any discrepancies were reexamined until agreement between coregistrations was obtained.
TCFA and Thick-Capped Fibroatheroma Categories
TCFAs and thick-capped fibroatheroma (ThCFAs) were identified by fibrous cap thickness (<65 or >65 μm, respectively). TCFAs were categorized by IVOCT as acute or obtuse by lipid arc <1 or >1 quadrant, respectively. The lipid arc was measured from the center of the lumen in the IVOCT image. Image segments of all 18 obtuse IVOCT TCFAs and 18 non-IVOCT TCFA image segments randomly selected from the University of Texas Health Science Center San Antonio (UTHSCSA) data set were mixed together and sent for external review at an independent IVOCT core laboratory (Massachusetts General Hospital [MGH]), which was blinded to the histology. Two experts in coronary artery pathology evaluated all histology sections. κ coefficients of inter-rater reliability were calculated for both of the previous analyses. Figure 2 describes the categorization of the 5 types of lesions identified in this study: true TCFA, ThCFA identified as TCFA (by IVOCT), true ThCFA, false TCFA, and false ThCFA.
Light-Scattering Mechanisms
To identify additional IVOCT light-scattering mechanisms that resulted in the false appearance of lipid, IVOCT images that had fibrous caps <65 μm and lipid arcs of any length were included in our analysis. The current IVOCT working group consensus document 3 does not define IVOCT TCFA based on the lipid arc and accepts lipid arcs <1 quadrant. 
Statistical Methods
Sensitivity, specificity, PPV, and negative predictive value and their 95% confidence intervals were calculated by frame by assigning each IVOCT frame a value of true-positive, true-negative, false-positive, or false-negative. Continuously distributed outcomes are summarized as mean ±1 SD. Estimates and confidence intervals for sensitivity, specificity, PPV, and negative predictive value were based on generalized estimating equation models with a logit link and adjustment for repeated measurements within subject using SAS version 9.4 (SAS Institute, Cary, NC). TCFAs were categorized by lipid arc: (1) obtuse and (2) all (acute and obtuse). Statistical data were generated for both categories of TCFA.
Results
IVOCT TCFA
A total of 18 obtuse IVOCT TCFA were identified: 8 (44%) were true TCFA, 3 (17%) were ThCFA that appeared as TCFA, and 7 (39%) were false TCFA. Length, fibrous cap thickness, and lipid pool arc are summarized by IVOCT TCFA (true TCFA, ThCFA as TCFA, and false TCFA) in Table 1 . Figure 3 demonstrates an example of a lesion characterized as a true TCFA. False TCFAs were caused by many etiologies ( Table 2) 
Light-Scattering Mechanisms
Sixty-three IVOCT fibroatheromas (45 IVOCT TCFAs and 18 IVOCT ThCFAs) of any lipid arc angle (obtuse and acute) were included for analysis. A total of 45 IVOCT TCFAs were identified: 12 (27%) were true TCFA, 8 (18%) were ThCFA that appeared as TCFA, and 25 (56%) were false TCFA. A total of 18 IVOCT ThCFAs were identified: 9 (50%) were true ThCFA and 9 (50%) were false ThCFA. The histological causes associated with each true or false IVOCT TCFA or IVOCT ThCFA are summarized in Table 3 . Examples of false TCFA include hypocellular and proteoglycan-rich regions (Figure 6 ), SMCrich fibrous tissue (Figure 7) , and a calcified nodule (Figure 8 ).
Accuracy
Sensitivity, specificity, PPV, and negative predictive value for IVOCT TCFA detection are summarized in Tables 4 and   Table 2 5 by lipid arc (all and obtuse). Sensitivity was numerically increased for all angles relative to obtuse (all 87% and obtuse 63%) and specificities were similar (all 92% and obtuse 96%), whereas PPV was decreased for all angles relative to obtuse (all 37% and obtuse 47%) and negative predictive values were similar (all 99% and obtuse 98%). The κ coefficient for 
Discussion
New mechanisms for the appearance of false IVOCT TCFA are identified including SMCs in the fibrous cap and loose connective tissue being mistaken for the lipid core. Foam cell accumulation in the fibrous cap has previously been reported to cause the appearance of false TCFA. 3, 7, 8, 10 Newly described are the importance of histological ThCFA that appear as IVOCT TCFA, and the false IVOCT appearance of a lipid core under a thick fibrous cap when no histological ThCFA is present-both due primarily to infiltration of foam cells.
We found that the most common mechanisms for the false appearance of IVOCT TCFA and IVOCT ThCFA were punctate or clustered foam cells. Although previous reports suggest that superficial foam cell infiltration may cause the appearance of TCFA, 7, 8 the high frequency with which this occurs is an important finding of this study and confirms the findings of Fujii et al. 10 Because atherosclerosis is an inflammatory disease, the high prevalence of foamy macrophages in our samples was expected. Foam cells can cause the appearance of Many true histological TCFA were missed by IVOCT with the requirement that >1 quadrant contain lipid (n=4). Furthermore, no consensus has been met about how many quadrants of an IVOCT image (or the lipid arc) should be dark to be considered a TCFA. 3 Our results argue against an IVOCT requirement of >1 quadrant to define a TCFA. Of 12 true TCFAs, 8 had lipid cores that extended >1 quadrant by IVOCT, 10 had lipid cores that extended >1 quadrant by histology, and 7 had lipid cores that extended >1 quadrant by both IVOCT and histology. In fact, our sensitivity increased from 63% to 87% by categorizing all lipid arcs as TCFAs instead of only including obtuse lipid arcs. Further validation of the number of IVOCT defined quadrants or lipid pool arc should be investigated to determine a more accurate definition of IVOCT identified TCFA. Arc measurements taken with IVOCT images may Figure I in the Data Supplement suggests a tendency for invasive imaging to overestimate TCFA frequency compared with histology, consistent with the results of our study. Furthermore, the discrepancies between IVOCT and histological TCFA studies could be because of the high false-positive rate of IVOCT for detecting TCFA as demonstrated in this study. Additional studies are needed to resolve these apparent discrepancies.
Lipid will generally appear dark in IVOCT images-whether foam cell accumulations, early lesions with extracellular lipid, or advanced lesions with necrotic cores. 10 Lipid is sometimes described as dark in IVOCT images because it absorbs incident light. A more detailed examination of the optical properties of lipid demonstrate, however, that the absorption coefficient (that determines how much light is absorbed) is relatively small for lipid, 25 and all plaque constituents in general, 26 at the wavelengths used by IVOCT (1310±50 nm). Additionally at this wavelength, the scattering coefficients (that determine how much light is scattered) for all constituents in the arteries are much larger than the absorption coefficients. 8, 26 Thus, we suggest that lipid is dark in IVOCT images because of a type 2-A light-scattering mechanism that is caused by homogenous pools of lipid with little variation in IR, rather than because of lipid absorbing incident IVOCT light. Indeed, any regions of homogenous plaque components with little variation in IR will appear dark in IVOCT images predominantly because of reduced light backscattering and not because of increased absorption.
To gain a better understanding on the natural history of TCFAs (eg, why some rupture and others thicken, and how pharmaceutical agents interact with TCFAs), an in vivo imaging system is needed that can improve the limited PPV identified in the current study. One possibility is to couple a second imaging modality with IVOCT-for instance, intravascular ultrasound, 10, 27 fluorescence lifetime imaging microscopy, 28 near-infrared fluorescence, 29 spectral OCT, 30 or 2-photon luminescence. 31, 32 Two-photon luminescence is an interesting candidate having the ability to image the actual molecular composition of plaque without the use of exogenous contrast agents. For instance, 2-photon luminescence confirmation of the absence of lipid in our TCFA database could have increased PPV to 55% (data not shown). Thus, these multimodal imaging systems all have the advantage of higher PPV over IVOCT alone and may be able to better differentiate between true and false TCFA by specifically identifying the presence or absence of lipid pools.
Limitations
The results from this small subset of hearts should be validated by a larger study to confirm and expand on the mechanisms of light dropout that appear as TCFAs. Histological coregistration is inherently difficult with imaging studies, and the histological sections are 5-μm thick compared with the 267-μm pitch in IVOCT images. However, the fine serial sectioning of every 120 µm used in the current study greatly improved the accuracy of coregistration. Also, distortions caused by histological processing are always possible sources of error in coregistration and IVOCT image interpretation. Finally, the imaging system we used was from Volcano Corporation, which is not currently clinically available. The optics in the Volcano system are similar to current clinically available systems, however, and thus the results will be applicable to other IVOCT imaging platforms. 
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